XYLOSE Drug Patent Profile
✉ Email this page to a colleague
When do Xylose patents expire, and when can generic versions of Xylose launch?
Xylose is a drug marketed by Lyne and is included in one NDA.
The generic ingredient in XYLOSE is xylose. There is one drug master file entry for this compound. Additional details are available on the xylose profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for XYLOSE?
- What are the global sales for XYLOSE?
- What is Average Wholesale Price for XYLOSE?
Summary for XYLOSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 4 |
| Patent Applications: | 5,735 |
| DailyMed Link: | XYLOSE at DailyMed |
Recent Clinical Trials for XYLOSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sintesi Research Srl | Phase 2 |
| Indena S.p.A | Phase 2 |
| L'Oreal | N/A |
US Patents and Regulatory Information for XYLOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lyne | XYLOSE | xylose | POWDER;ORAL | 018856-001 | Mar 26, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
